Description

Invanz Lyophilisate for Solution for Injections 1g. №1 Vial

Ingredients:

Each vial contains 1g of Ertapenem (as sodium).

Dosage:

The recommended dosage for adults is 1g administered once a day. Dosage adjustments may be needed based on the severity of the infection and renal function.

Indications:

Invanz is indicated for the treatment of various infections, including complicated intra-abdominal infections, complicated skin and skin structure infections, and community-acquired pneumonia.

Contraindications:

Do not use Invanz if there is a known hypersensitivity to Ertapenem or any component of the formulation. Caution is advised in patients with a history of seizures.

Directions:

Invanz is for intravenous or intramuscular use only. It should be reconstituted and administered as directed by a healthcare provider.

Scientific Evidence:

Invanz has demonstrated efficacy in various clinical trials. Studies have shown that Ertapenem is effective against a wide range of gram-positive and gram-negative bacteria, making it a valuable option for the treatment of serious infections.

Pharmacological Effects: Ertapenem exerts its antibacterial effects by inhibiting cell wall synthesis in bacteria, leading to cell death. It has a broad spectrum of activity and good tissue penetration, making it effective against many pathogens.

Comparative Effectiveness: In comparative studies, Invanz has shown similar efficacy to other carbapenem antibiotics with a favorable safety profile. Its once-daily dosing regimen offers convenience and may improve patient adherence to treatment.